Low expression of CD54 on lymphoma cells from primary sites is related to an advanced stage, extranodal involvement, BM infiltration, poor therapeutic response, and worse survival in aggressive B-cell lymphoma [32]. This evidence concerns the gene ICAM1 and lymphoma.